Acalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic Leukemia
Conditions
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
Interventions
- DRUG: Acalabrutinib
- BIOLOGICAL: Obinutuzumab
Sponsor
M.D. Anderson Cancer Center
Collaborators